In March 2025, the company introduced new designs for a immediate-to-client offering of its Wegovy weight loss drug. The company established a brand new pharmacy, referred to as NovoCare, which would charge buyers $499 every month for entry to the drug, fewer than fifty percent the price of the drug by way of other pharmaceutical distribution netwo